Literature DB >> 21843496

A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.

Joelle Renneson1, Rodrigo Guabiraba, Isabelle Maillet, Rafael E Marques, Stoyan Ivanov, Josette Fontaine, Christophe Paget, Valérie Quesniaux, Christelle Faveeuw, Bernhard Ryffel, Mauro M Teixeira, François Trottein.   

Abstract

Dengue virus (DENV), a member of the mosquito-borne flaviviruses, is a serious public health problem in many tropical countries. We assessed the in vivo physiologic contribution of invariant natural killer T (iNKT) cells, a population of nonconventional lipid-reactive αβ T lymphocytes, to the host response during experimental DENV infection. We used a mouse-adapted DENV serotype 2 strain that causes a disease that resembles severe dengue in humans. On DENV challenge, splenic and hepatic iNKT cells became activated insofar as CD69 and Fas ligand up-regulation and interferon-γ production. C57BL/6 mice deficient in iNKT cells (Jα18(-/-)) were more resistant to lethal infection than were wild-type animals, and the phenotype was reversed by adoptive transfer of iNKT cells to Jα18(-/-) animals. The absence of iNKT cells in Jα18(-/-) mice was associated with decreased systemic and local inflammatory responses, less liver injury, diminished vascular leak syndrome, and reduced activation of natural killer cells and neutrophils. iNKT cell functions were not necessary for control of primary DENV infection, after either natural endogenous activation or exogenous activation with the canonical iNKT cell agonist α-galactosylceramide. Together, these data reveal a novel and critical role for iNKT cells in the pathogenesis of severe experimental dengue disease.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843496      PMCID: PMC3181339          DOI: 10.1016/j.ajpath.2011.06.023

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  88 in total

1.  Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.

Authors:  Branka Grubor-Bauk; Anthony Simmons; Graham Mayrhofer; Peter G Speck
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 2.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.

Authors:  Alena Atrasheuskaya; Peter Petzelbauer; Terry M Fredeking; George Ignatyev
Journal:  FEMS Immunol Med Microbiol       Date:  2003-01-21

4.  Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.

Authors:  Ofer Levy; Jordan S Orange; Patricia Hibberd; Sharon Steinberg; Phillip LaRussa; Adriana Weinberg; S Brian Wilson; Angela Shaulov; Gary Fleisher; Raif S Geha; Francisco A Bonilla; Mark Exley
Journal:  J Infect Dis       Date:  2003-09-26       Impact factor: 5.226

5.  Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization.

Authors:  Kala Jessie; Mun Yik Fong; Shamala Devi; Sai Kit Lam; K Thong Wong
Journal:  J Infect Dis       Date:  2004-04-05       Impact factor: 5.226

6.  Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.

Authors:  Emanuele Durante-Mangoni; RuoJie Wang; Angela Shaulov; Qi He; Imad Nasser; Nezam Afdhal; Margaret J Koziel; Mark A Exley
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection.

Authors:  Ali A Ashkar; Kenneth L Rosenthal
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Innate immune response to encephalomyocarditis virus infection mediated by CD1d.

Authors:  Mark A Exley; Nancy J Bigley; Olivia Cheng; Angela Shaulov; Syed Muhammad Ali Tahir; Quincy L Carter; Jorge Garcia; Carren Wang; Kurt Patten; Harold F Stills; Frederick W Alt; Scott B Snapper; Steven P Balk
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

9.  Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.

Authors:  Sujan Shresta; Jennifer L Kyle; Heidi M Snider; Manasa Basavapatna; P Robert Beatty; Eva Harris
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

View more
  21 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 2.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

3.  Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development.

Authors:  Rafael E Marques; Rodrigo Guabiraba; Juliana L Del Sarto; Rebeca F Rocha; Ana Luiza Queiroz; Daniel Cisalpino; Pedro E Marques; Carolina C Pacca; Caio T Fagundes; Gustavo B Menezes; Maurício L Nogueira; Danielle G Souza; Mauro M Teixeira
Journal:  Immunology       Date:  2015-06-01       Impact factor: 7.397

4.  Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.

Authors:  Eiichiro Kawai; Fumitaka Sato; Seiichi Omura; Nicholas E Martinez; Pratap C Reddy; Masaru Taniguchi; Ikuo Tsunoda
Journal:  J Neuroimmunol       Date:  2014-11-08       Impact factor: 3.478

5.  Interleukin-33 contributes to disease severity in Dengue virus infection in mice.

Authors:  Rafael E Marques; Anne-Gaëlle Besnard; Isabelle Maillet; Caio T Fagundes; Danielle G Souza; Bernhard Ryffel; Mauro M Teixeira; Foo Y Liew; Rodrigo Guabiraba
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

6.  T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.

Authors:  Marcela Helena Gonçalves Pereira; Maria Marta Figueiredo; Camila Pereira Queiroz; Télcia Vasconcelos Barros Magalhães; Adriana Mafra; Lilian Martins Oliveira Diniz; Último Libânio da Costa; Kenneth J Gollob; Lis Ribeiro do Valle Antonelli; Helton da Costa Santiago
Journal:  Immunology       Date:  2020-04-06       Impact factor: 7.397

7.  West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.

Authors:  S Kovats; S Turner; A Simmons; T Powe; E Chakravarty; J Alberola-Ila
Journal:  Clin Exp Immunol       Date:  2016-09-22       Impact factor: 4.330

Review 8.  Dengue virus infection: current concepts in immune mechanisms and lessons from murine models.

Authors:  Rodrigo Guabiraba; Bernhard Ryffel
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

9.  Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection.

Authors:  A Kamaladasa; N Wickramasinghe; T N Adikari; L Gomes; N L A Shyamali; M Salio; V Cerundolo; G S Ogg; G Neelika Malavige
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

Review 10.  Dengue in India.

Authors:  Nivedita Gupta; Sakshi Srivastava; Amita Jain; Umesh C Chaturvedi
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.